血管内皮细胞在瘤转移中的作用
Ying Feng1, Shan Luo2, Dandan Fan3
1Department of Critical Care Medicine, Hubei Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China.
Acta histochemica
|June 22, 2023
概括
血管内皮细胞 (VEC) 在瘤进展和转移中至关重要. 向VEC为有效的抗瘤疗法提供了有希望的新途径.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 血管生物学 血管生物学
背景情况:
- 血管内皮细胞 (VECs) 形成血管内膜,调节血管系统功能.
- VECs 形成紧密的结节,作为阻碍瘤细胞输入/输出血管的障碍.
- 像增殖和迁移这样的VEC功能对于瘤血管生成和恶性进展至关重要.
研究的目的:
- 综合审查VECs在瘤进展和转移中的多方面的作用.
- 阐明VECs影响瘤生长和扩散的潜在机制.
- 探索用于新型抗瘤疗法的VEC向策略.
主要方法:
- 对癌症中VECs现有研究的文献综述.
- 对VEC参与瘤血管生成和免疫规避的分析.
- 在瘤进展过程中检查VEC中的内皮细胞到介质细胞过渡 (EndMT).
主要成果:
- 瘤转移的关键驱动因素之一是VEC功能障碍.
- VECs通过细胞因子分泌来调节瘤干.
- 在VEC中EndMT加剧了瘤的进展.
- VECs影响免疫细胞透到瘤中.
结论:
- VECs在调节瘤进展,转移和免疫反应方面发挥着至关重要的作用.
- 针对VEC的治疗策略在癌症治疗方面具有重大潜力.
- 了解VEC机制为开发新型抗癌药物提供了洞察力.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K


